News – Archive

Grindeks and Kalceks will participate in the world’s largest pharmaceutical exhibition “CPhI Worldwide 2019

From November 5 to 7 in Frankfurt (Germany), one of the most anticipated events in pharmacy – exhibition “CPhI Worldwide 2019” – will take place....

04/11/2019

Grindeks oxytocin inclusion in WHO List of Prequalified Medicinal Products provides new opportunities in international tenders

JSC Grindeks informs that World Health Organization (WHO) has included oxytocin solution for injection 10 IU/ml in the List of Prequalified Medicinal Products. JSC Grindeks...

22/10/2019

Grindeks congratulates winners of the International Chemistry Olympiad

On Friday, October 4, in Riga Castle, an awarding ceremony took place to honour participants of International Subjects Olympiads. By continuing to support new talents...

07/10/2019

Children neurologist Jurģis Strautmanis receives Grindeks highest professional honor D. H. Grindel award

On Friday, October 4, in The Large Hall of Latvian Union House, as part of Children’s Clinical University Hospital’s 120 years anniversary, children neurologist, electroencephalography...

07/10/2019

JSC Grindeks supports Children’s Clinical University Hospital 120th years’ anniversary activities

Today in Children’s Clinical University Hospital’s Sunny Days Library, presentation on hospital’s 120th years anniversary events will take place. JSC “Grindeks” has become a supporter...

02/10/2019

Grindeks profit in the first six months of 2019 increases by 14% and reaches 7.65 million euro

Today, on August 29, JSC Grindeks submitted the non-audited consolidated financial statements of the first six months of 2019 to Nasdaq Riga. Non-audited financial results...

29/08/2019

JSC Grindeks industrial wastewater treatment plants – 10 years anniversary!

This year JSC Grindeks celebrates 10 years anniversary of an important environmental protection project. On June 4, 2009, on the eve of the World Environment...

04/06/2019

Grindeks reaches 30.2 million euros turnover and 3.37 million euros profit in the first three months of 2019

Today, on 30 May, the JSC Grindeks submitted the non-audited consolidated financial statements of the first three months of 2019 to Nasdaq Riga. Non-audited financial...

30/05/2019

JSC Grindeks receives Gold in “Trade Mark 2018” competition in Ukraine

In the annual Ukrainian competition “Trade Mark 2018” („Фавориты Успеха”) JSC Grindeks product Viprosal B®* has received Golden Award in “Muscle and Joint Pain Treatment”...

28/05/2019